Rheumatoid Demographics: RA is a common chronic disease that affects about 1% of the worlds population
While initiation of motor neuron degeneration appears cell-intrinsic, other cell types including astrocytes, microglia, and T-lymphocytes are key components in the disease progression of ALS, and cell transplantation could more effectively be targeted at replacing these cell types rather than motor neurons
I kind of liken it to what were going through with cryptocurrency and the legacy financial system. Opt Health doctors use phrases like buyer beware, nascent industry, and kind of rogue right now. Peptides prescribed by wellness clinics are made and sold by compounding pharmacies with minimal standardization

Metabolism & Elimination Limited characterization of specific metabolic pathways has been published for both peptides: CJC-1295 (NO DAC): Peptidase-mediated degradation represents primary metabolic pathway Four amino acid substitutions provide enhanced resistance to dipeptidyl peptidase-IV Metabolites and degradation products not fully characterized in published literature Clearance from circulation within hours despite sustained pharmacodynamic effects Ipamorelin: Clearance of 0.078 L/h/kg in human pharmacokinetic studies Rapid elimination from plasma following distribution phase Metabolic pathways likely involve proteolytic cleavage at peptide bonds No significant accumulation observed with repeated dosing in animal models A notable pharmacokinetic-pharmacodynamic disconnect exists: despite relatively short plasma half-lives (30 minutes to 2 hours), growth hormone secretory effects persist for 6+ hours, suggesting either active metabolites, tissue retention, or persistent receptor signaling cascade activation

Instead of restoring balance, this non-specific scavenging strategy likely blunted essential, low-level ROS signals required for activating endogenous protective pathways, paradoxically leaving the myocardium more vulnerable
When combined with clinical assessment and provider guidance, genetic insights from the Precision Peptide Genetic Test may help you and your healthcare team develop a more personalized GLP-1 protocolsuch as PlexusDx Microdose GLP-1 Protocol ($129/month) or oral semaglutide ($289/mo starting)designed to optimize tolerability during the critical adjustment phase